Comment
Author: Admin | 2025-04-28
HomeTrelegy ElliptaDrug Interactions There are 533 drugs known to interact with Trelegy Ellipta (fluticasone/umeclidinium/vilanterol), along with 13 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 55 are major, 460 are moderate, and 18 are minor. Does Trelegy Ellipta interact with my other drugs? Enter medications to view a detailed interaction report using our Drug Interaction Checker. View all 533 medications that may interact with Trelegy Ellipta View Trelegy Ellipta alcohol/food interactions (2) View Trelegy Ellipta disease interactions (13) Most frequently checked interactions View interaction reports for Trelegy Ellipta (fluticasone / umeclidinium / vilanterol) and the medicines listed below. Major Moderate Minor Unknown albuterol amlodipine aspirin atorvastatin carvedilol Eliquis (apixaban) famotidine fluticasone nasal furosemide gabapentin hydrochlorothiazide levothyroxine lisinopril losartan metformin metoprolol Metoprolol Succinate ER (metoprolol) montelukast omeprazole pantoprazole potassium chloride prednisone rosuvastatin Singulair (montelukast) tamsulosin tramadol trazodone Ventolin HFA (albuterol) Vitamin B12 (cyanocobalamin) Vitamin D3 (cholecalciferol) View all Trelegy Ellipta alcohol/food interactions There are 2 alcohol/food interactions with Trelegy Ellipta (fluticasone / umeclidinium / vilanterol). Trelegy Ellipta disease interactions There are 13 disease interactions with Trelegy Ellipta (fluticasone / umeclidinium / vilanterol) which include: milk protein allergies cardiovascular diabetes hypokalemia seizures anticholinergic effects hepatic impairment infections ocular herpes simplex ocular toxicities osteoporosis hyperadrenocorticism severe liver impairment Report options Drug Interaction Classification These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication. Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. Unknown No interaction information available. Further informationAlways consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.Medical Disclaimer
Add Comment